LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.8%, EPS grew 296.0%, free cash flow fell 26.7% and total debt fell 31.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

77.60 0.90 −1.15%
Market cap
$4.3B
P/E
22.5×
Fwd P/E
26.0×
Dividend yield
—
F-score
4/9
Altman Z
1.74
Beneish M
−3.30
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 32.26 23.83
P/S ratio
2.12 2.42 2.42 3.07
P/FCF ratio
15.21 18.94 21.07 29.69
P/Operating CF
33.64 40.73 228.44 67.88
P/B ratio
2.47 2.80 2.87 3.41
Price to Tangible BV
21.73 18.94 17.28 13.73
EV/Sales
1.96 2.23 2.25 2.92
EV/EBITDA
9.65 10.98 11.73 15.76
EV/Operating CF
10.57 12.18 13.13 17.24
EV/FCF
14.08 17.48 19.54 28.23
Quick Ratio
1.04 1.05 1.01 1.06
Current Ratio
1.33 1.36 1.33 1.45
Net Debt/EBITDA
(2.82) (4.10) (4.07) (3.07)
Debt/Assets
16.99% 14.45% 11.44% 11.11%
Debt/Equity
0.38 0.31 0.24 0.22
Asset Turnover
0.53 0.54 0.56 0.57
Operating CF/Net income
3.18 2.67 0.68 0.61
Capex/Depreciation
(1.09) (1.22) (0.70) (1.36)
Interest Coverage
4.97 5.19 5.00 6.90
Research and Development Expense of Revenue
13.58% 14.44% 16.20% 13.74%
Selling, General and Administrative Expense of Revenue
38.72% 39.72% 39.63% 40.48%
Intangible Assets out of Total Assets
0.40 0.39 0.40 0.38
Share Based Compensation of Revenue
2.78% 2.60% 2.28% 4.32%
Graham Net Nets
(0.11) (0.09) (0.08) (0.06)
Graham Number
0.00 0.00 31.33 43.26
Earnings Yield
(7.62%) (7.23%) 3.10% 4.20%
Free Cash Flow Yield
6.58% 5.28% 4.75% 3.37%
Revenue per Share
6.55 6.62 6.62 7.11
Operating CF per Share
1.56 1.51 0.28 1.21
Capex per Share
(0.42) (0.46) (0.26) (0.57)
Free Cash Flow per Share
1.14 1.05 0.02 0.64
Cash per Share
11.83 11.65 9.87 9.40
Shareholders Equity per Share
21.18 22.00 22.15 24.11
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
21.18 22.00 22.15 24.11
Free Cash Flow
62.18 57.45 0.93 35.04
Working Capital
269.56 293.54 251.76 318.04
Capital Expenditures
(22.88) (24.95) (14.29) (31.55)
Net Current Asset Value
(303.20) (304.45) (290.79) (290.49)
EV/EBIT
13.67 15.53 16.77 22.91
Capex to Sales
0.06 0.07 0.04 0.08
Price to Operating Income
14.76 16.83 18.08 24.10
Other line items
Average Receivables
204.37 204.57 215.68 225.75
Average Payables
83.02 83.44 93.39 95.16
Average Inventory
164.90 156.13 159.76 168.98
Average Assets
2,539.77 2,556.22 2,537.55 2,573.78
Average Common Equity
1,233.64 1,260.12 1,122.81 1,224.08

Fold the line items

Columns are period end dates